Copyright
©The Author(s) 2022.
World J Clin Cases. Oct 26, 2022; 10(30): 11162-11171
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.11162
Published online Oct 26, 2022. doi: 10.12998/wjcc.v10.i30.11162
Figure 1 Magnetic resonance imaging and pathology at first recurrence.
A-C: Brain magnetic resonance imaging (MRI) T1-weighted postcontrast image (A) axial, (B) sagittal, (C) transverse,which indicates hyperintensity and intracapsular hypointense signals after contrast enhancement in the right cerebellopontine angle tumor (arrow); D and E: Axial MRI T2-weighted image shows a heterogeneous lightly hypointense node beside the hyperintense capsule, while axial MRI T1-weighted image (E) shows a heterogeneous lightly hyperintense node and hypointense capsule (October 24, 2000, before the 2nd operation); F: Histology shows recurrent melanoma (hematoxylin-eosin staining, magnification × 400).
- Citation: Wong TF, Chen YS, Zhang XH, Hu WM, Zhang XS, Lv YC, Huang DC, Deng ML, Chen ZP. Longest survival with primary intracranial malignant melanoma: A case report and literature review. World J Clin Cases 2022; 10(30): 11162-11171
- URL: https://www.wjgnet.com/2307-8960/full/v10/i30/11162.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i30.11162